Sanofi’s Hostile Bid for Aventis Rejected
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 45 (Table of Contents)
Published: 4 Mar-2004
DOI: 10.3833/pdr.v2004.i45.825 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Following intense market speculation of merger discussions between Sanofi-Synthelabo and Aventis, Sanofi-Synthelabo intended to acquire Aventis shares...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS